HIV Rapid Test Kits Market – Trends and Forecasts by Technavio

04-Oct-2017 Intellasia | BusinessWire | 11:33 PM Print This Post

LONDON–(BUSINESS WIRE)–#HIVtestkits–Technavio’s latest report on the global
human immunodeficiency virus (HIV) rapid test kits market
an analysis of the most important trends expected to impact the market
outlook from 2017-2021. Technavio
defines an emerging trend as a factor that has the potential to
significantly impact the market and contribute to its growth or decline.

The global HIV rapid test kits market will grow at a moderate pace
during the forecast period. The rapid testing methods monitor critical
control points in real time, thereby have reduced the turn-around-time
(TAT) of disease identification. Rapid test kits improve the
manufacturing process, ensure product safety, and decrease the overall
cost. Owing to low-cost and better efficacy, regulatory bodies such as
the US FDA, European Medicines Agency (EMA), Australian Therapeutic
Goods Administration (TGA), Japanese pharmaceuticals, and regulatory
bodies of other countries encourage the adoption of rapid HIV testing

Srinivas Sashidhar, a lead analyst from Technavio, specializing in
research on in-vitro
sector, says, “Many campaigns have been organized by
governments to educate people about HIV, AIDS, and the advantages of HIV
rapid testing kits. Such initiatives increase the demand for HIV rapid
test kits. For instance, the US government along with the CDC developed
HIV prevention plans for HIV affected population.”

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

Buy 1 Technavio report and get the second for 50% off. Buy 2
Technavio reports and get the third for free.

The top three emerging trends driving the global HIV
rapid test kits market
according to Technavio research
analysts are:

  • Growing preference for self-testing
  • Increase in testing programs to prove the accuracy of rapid test kits
  • Growth in campaigns to educate people about HIV

Looking for more information on this market? Request
a free sample report

Technavio’s sample reports are free of charge and contain multiple
sections of the report including the market size and forecast, drivers,
challenges, trends, and more.

Growing preference for self-testing

HIV self-testing in home setting only marks the presence of HIV-1/2
antibodies or the HIV-1 p24 antigen; it does not provide a diagnosis.
The self-testing kit has an inbuilt control line, which makes the
performance of the test accurate and reliable. The increasing preference
for the self-testing procedure will drive the adoption of the HIV rapid
test kits among people.

“The U.S. Agency for International Development approved Chembio
Diagnostic Systems’ DPP HIV 1/2 Assay in February 2017. This product is
CLIA-waived and offers 95% specificity and sensitivity. It produces
result within 10-25 minutes for blood detection and oral detection it
takes 25-40 minutes,”
according to Srinivas.

Increase in testing programs to prove the accuracy of rapid test kits

The increasing testing programs by the vendors will prove the accuracy
and effectivity of the product, which, in turn, will attract the
end-users. For instance, in April 2016, Alere in association with the
CDC formed a testing program for its rapid test kit Alere Determine
HIV-1/2 Ag/Ab Combo. The product can detect HIV-1 p24 antigen and HIV-1
and HIV-2 antibodies.

A study conducted by the CDC in April 2016 revealed that Determine Combo
by Alere can detect infection within 1-2 weeks by comparing it with all
other FDA-approved tests on the same plasma specimens, HIV-1 p24
antigen, and HIV-1 and HIV-2 antibodies. This reduces TAT, which helps
in providing early treatment to the patients affected by HIV.

Growth in campaigns to educate people about HIV

In April 2017, the campaign, #Live2LUV helped in promoting education on
sexual wellness which included HIV among the young population of
South-East Asian countries. The organizations such as UNAIDS in
association with Youth Lead and Youth Voices Count, the United Nations
Children’s Fund and the United Nations Population Fund launched a four
days campaign in association with the Association of Southeast Asian
Nations (ASEAN) Youth Summit in the Philippines.

In APAC, young people account for 37% of new HIV infections. Data show
that young people from key populations are at even higher risk of HIV
infection than their older counterparts. For example, in Thailand, among
young gay men and other men who have sex with men HIV prevalence is 11%,
compared with 8.3% among gay men and other men who have sex with men who
are 25 years and older. Therefore, it will help in promoting education
about HIV.

The key vendors are as follows:

  • F. Hoffmann-La Roche
  • Alere

Browse Related Reports:

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at [email protected].


Technavio Research
Jesse Maida
Media & Marketing Executive
+1 844 364 1100
UK: +44 203 893 3200


Category: BusinessWire, PRAsia

Print This Post